Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to elucidate whether or not angiotensin II receptor blockers
(ARB) are more beneficial or equal to angiotensin converting enzyme inhibitors (ACEI) on
development or progression of silent brain infarction and cognitive decline in Japanese
patients with essential hypertension in the elderly.
Phase:
Phase 4
Details
Lead Sponsor:
Nara Medical University
Treatments:
Angiotensin II Angiotensin II Type 1 Receptor Blockers Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Angiotensinogen Enzyme Inhibitors Giapreza